|
PF-48151 |
ABACAVIR Landsteiner 300 mg Tabletas Recubiertas |
2017-12-14 |
|
Landsteiner Scientific, S.A. de C.V. |
Mexico
|
Almar Médica |
Mederik |
Droguería Colón |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48283 |
INDINAVIR Landsteiner 400 mg Cápsulas |
2018-02-06 |
|
Landsteiner Scientific, S.A. de C.V. |
Mexico
|
Almar Médica |
Mederik |
Droguería Colón |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48344 |
TACROLIMUS Landsteiner 1.0 mg Cápsulas |
2023-02-22 |
|
Landsteiner Scientific, S.A. de C.V. |
Mexico
|
Almar Médica |
Almar Diagnóstica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48600 |
ITRACONAZOL Landsteiner 100 mg Cápsulas |
2018-05-24 |
|
Landsteiner Scientific, S.A. de C.V. |
Mexico
|
Almar Médica |
Mederik |
Almar Diagnóstica |
Droguería Colón |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-48712 |
IMIQUIMOD Landsteiner 5% Crema tópica |
2018-06-24 |
|
Landsteiner Scientific, S.A. de C.V. |
Mexico
|
Almar Médica |
Mederik |
Almar Diagnóstica |
Droguería Colón |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49202 |
MICOFENOLATO DE MOFETILO Landsteiner 250 mg cápsula |
2018-10-24 |
|
Landsteiner Scientific, S.A. de C.V. |
Mexico
|
Almar Médica |
Mederik |
Droguería Colón |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49239 |
TACROLIMUS Landsteiner 0.5 mg Cápsulas |
2023-10-30 |
|
Landsteiner Scientific, S.A. de C.V. |
Mexico
|
Almar Médica |
Mederik |
Droguería Colón |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52345 |
LANTOX 50 Unidades Liofilizado para solución inyectable |
2021-01-04 |
|
Lanzhou Institute Of Biological Products Co., Ltd. |
República de China
|
Skinpharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31029 |
TOXINA BOTULINICA Tipo A Lanzhou 100 U Polvo Liofilizado para Uso * |
2008-07-23 |
|
Lanzhou Institute Of Biological Products Co., Ltd. |
República de China
|
Diprofesa V & B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31030 |
TOXINA BOTULÍNICA Tipo A Lanzhou 50 unidades, polvo liofilizado para * |
2008-07-23 |
|
Lanzhou Institute Of Biological Products Co., Ltd. |
República de China
|
Diprofesa V & B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|